Literature DB >> 8968783

Clinical assessment of human gonadotrophins produced by recombinant DNA technology.

E Loumaye1, I Martineau, A Piazzi, L O'Dea, S Ince, C Howles, G Decosterd, K Van Loon, A Galazka.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8968783     DOI： 10.1093/humrep/11.suppl_5.95

Source DB:  PubMed          Journal:  Hum Reprod        ISSN： 0268-1161            Impact factor:   6.918


× No keyword cloud information.
  8 in total

Review 1.  Novel Concepts for Inducing Final Oocyte Maturation in In Vitro Fertilization Treatment.

Authors:  Ali Abbara; Sophie A Clarke; Waljit S Dhillo
Journal:  Endocr Rev       Date:  2018-10-01       Impact factor: 19.871

2.  Comparing the efficacy of urinary and recombinant hCG on oocyte/follicle ratio to trigger ovulation in women undergoing intracytoplasmic sperm injection cycles: a randomized controlled trial.

Authors:  Tahereh Madani; Ladan Mohammadi Yeganeh; Zahra Ezabadi; Fatemeh Hasani; Mohammad Chehrazi
Journal:  J Assist Reprod Genet       Date:  2012-12-29       Impact factor: 3.412

3.  Recombinant follitropin alfa/lutropin alfa in fertility treatment.

Authors:  Ahmed Gibreel; Siladitya Bhattacharya
Journal:  Biologics       Date:  2010-02-04

4.  Review of the safety, efficacy, costs and patient acceptability of recombinant follicle-stimulating hormone for injection in assisting ovulation induction in infertile women.

Authors:  Marleen Nahuis; Fulco van der Veen; Jur Oosterhuis; Ben Willem Mol; Peter Hompes; Madelon van Wely
Journal:  Int J Womens Health       Date:  2010-08-09

5.  Economic evaluation of alternative assisted reproduction techniques in management of infertility in Greece.

Authors:  Vassilis Fragoulakis; Georgia Kourlaba; Basil Tarlatzis; Minas Mastrominas; Nikolaos Maniadakis
Journal:  Clinicoecon Outcomes Res       Date:  2012-07-12

6.  Recombinant versus highly-purified, urinary follicle-stimulating hormone (r-FSH vs. HP-uFSH) in ovulation induction: a prospective, randomized study with cost-minimization analysis.

Authors:  Alberto Revelli; Francesca Poso; Gianluca Gennarelli; Federica Moffa; Giuseppina Grassi; Marco Massobrio
Journal:  Reprod Biol Endocrinol       Date:  2006-07-18       Impact factor: 5.211

7.  Gonadotrophins for ovulation induction in women with polycystic ovary syndrome.

Authors:  Nienke S Weiss; Elena Kostova; Marleen Nahuis; Ben Willem J Mol; Fulco van der Veen; Madelon van Wely
Journal:  Cochrane Database Syst Rev       Date:  2019-01-16

8.  Comparison of highly purified urinary versus recombinant FSH: Effect on ART outcomes in polycystic ovary syndrome.

Authors:  Farnaz Sohrabvand; Shahrzad Sheikhhassani; Maryam Bagheri; Fedyeh Haghollahi; Maryam Shabihkhani; Mamak Shariat; Manijeh Nasr Esfahani
Journal:  Iran J Reprod Med       Date:  2012-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.